ANZ Group Holdings Ltd (ASX: ANZ) is scheduled to release its first quarter APS 330 report next Thursday, 20 February 2025.
In ANZ's most recent full-year results, the bank reported:
- Revenue down 2% to $20.55 billion
- Expenses up 4% to $10.55 billion
- Cash profit down 9.3% to $6.73 billion
Here's what to look for in next week's report.
Earnings
The first quarter APS 330 report provides information on the bank's capital adequacy and risk management practices, as required by the Australian Prudential Regulation Authority (APRA).
Previous APS 330 reports have focused on ANZ's risk profile, stability, and regulatory compliance rather than financial metrics like revenue, profit, or net interest margin (NIM) which are in ANZ's financial results and investor presentations.
ANZ typically publishes detailed financial performance metrics, including NIM and net profit after tax (NPAT), in its half- and full-year results announcements.
The next scheduled release is the half-year 2025 earnings results, expected in May 2025.
Dividends
Just like earnings, dividend amounts are typically announced during the half- and full-year results presentations.
Key 2025 dates for ANZ dividend announcements include:
Interim Dividend:
- Half-year results: Thursday, 8 May
- Ex-dividend date: Tuesday, 13 May
- Record date: Wednesday, 14 May
- Payment date: Tuesday, 1 July
Final Dividend:
- Full-year results: Monday, 10 November
- Ex-dividend date: Thursday, 13 November
- Record date: Friday, 14 November
- Payment date: Friday, 19 December
Estimates from Commsec predict ANZ is set to have the highest dividend yield of the big four banks in 2025.
Is now the time to buy ANZ shares?
Next week's report might not be a make-or-break moment for those considering ANZ shares.
The Motley Fool's Tristan Harrison identified a number of challenges earlier this month.
The bank is still under investigation for the government bond trading scandal, experiencing rising arrears on home loans and strong competition.
Despite these challenges, ANZ shares are up a healthy 14% over the last 12 months.
